Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)

CUSIP: 25056L103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
61,880,773
Total 13F shares
31,717,256
Share change
-1,154,099
Total reported value
$84,046,693
Put/Call ratio
130%
Price per share
$2.65
Number of holders
87
Value change
-$1,847,569
Number of buys
48
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 25056L103?
CUSIP 25056L103 identifies DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
11%
6,526,476
$15,402,483 30 Sep 2023
13F
SR One Capital Fund I Aggregator LP
3/4/5
10%+ Owner
class O/S missing
6,526,476
$15,317,639 16 Dec 2022
Logos Global Management LP
13F
Company
8.1%
5,032,501
$11,876,702 30 Sep 2023
13F
CITADEL ADVISORS LLC
13F
Company
4.4%
2,700,553
$6,373,305 30 Sep 2023
13F
RTW INVESTMENTS, LP
13F
Company
4.1%
2,512,986
$5,930,647 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
3.9%
2,403,915
$5,673,240 30 Sep 2023
13F
BAKER BROS. ADVISORS LP
13F
Company
2.4%
1,500,000
$3,540,000 30 Sep 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
2.2%
1,350,000
$3,186,000 30 Sep 2023
13F
Prosight Management, LP
13F
Company
1.9%
1,203,745
$2,840,838 30 Sep 2023
13F
Soleus Capital Management, L.P.
13F
Company
1.7%
1,025,000
$2,419,000 30 Sep 2023
13F
VANGUARD GROUP INC
13F
Company
1.6%
986,711
$2,328,638 30 Sep 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.3%
829,480
$1,957,573 30 Sep 2023
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
1.2%
716,818
$1,691,689 30 Sep 2023
13F
STATE STREET CORP
13F
Company
1.1%
692,723
$1,634,826 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1%
634,720
$1,498,082 30 Sep 2023
13F
Rock Springs Capital Management LP
13F
Company
0.74%
460,391
$1,086,523 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.72%
444,498
$1,049,016 30 Sep 2023
13F
Walleye Capital LLC
13F
Company
0.6%
373,513
$881,491 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
0.58%
360,258
$850,208 30 Sep 2023
13F
NORTHERN TRUST CORP
13F
Company
0.52%
323,259
$762,891 30 Sep 2023
13F
Assenagon Asset Management S.A.
13F
Company
0.4%
248,047
$585,391 30 Sep 2023
13F
S.c.a. Candriam
13F
Individual
0.36%
225,000
$531,000 30 Sep 2023
13F
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.29%
180,000
$425,000 30 Sep 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.28%
173,545
$409,566 30 Sep 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.27%
164,200
$388,000 30 Sep 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.25%
153,387
$361,993 30 Sep 2023
13F
Bank of New York Mellon Corp
13F
Company
0.2%
120,792
$285,069 30 Sep 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.18%
112,800
$266,208 30 Sep 2023
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.16%
100,722
$237,704 30 Sep 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
80,500
$189,980 30 Sep 2023
13F
STRS OHIO
13F
Company
0.12%
72,800
$171,000 30 Sep 2023
13F
BARCLAYS PLC
13F
Company
0.12%
71,678
$169,160 30 Sep 2023
13F
FMR LLC
13F
Company
0.11%
70,058
$165,337 30 Sep 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.1%
63,835
$150,651 30 Sep 2023
13F
MARSHALL WACE, LLP
13F
Company
0.1%
60,542
$142,878 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.09%
56,342
$132,967 30 Sep 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.09%
54,115
$127,799 30 Sep 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.08%
52,476
$123,835 30 Sep 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.08%
48,735
$115,015 30 Sep 2023
13F
Jump Financial, LLC
13F
Company
0.08%
46,700
$110,212 30 Sep 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.07%
43,581
$103,000 30 Sep 2023
13F
Squarepoint Ops LLC
13F
Company
0.07%
42,562
$100,446 30 Sep 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.07%
41,400
$97,704 30 Sep 2023
13F
XTX Topco Ltd
13F
Company
0.06%
38,472
$90,794 30 Sep 2023
13F
HSBC HOLDINGS PLC
13F
Company
0.06%
36,490
$85,569 30 Sep 2023
13F
ALGERT GLOBAL LLC
13F
Company
0.06%
35,620
$84,000 30 Sep 2023
13F
PDT Partners, LLC
13F
Company
0.05%
33,682
$79,490 30 Sep 2023
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
33,400
$78,824 30 Sep 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
29,383
$69,344 30 Sep 2023
13F
Corton Capital Inc.
13F
Company
0.04%
27,134
$64,036 30 Sep 2023
13F

Institutional Holders of Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN) as of Q4 2023

As of 31 Dec 2023, Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,717,256 shares. The largest 10 holders included SR ONE CAPITAL MANAGEMENT, LP, Logos Global Management LP, BlackRock Inc., CITADEL ADVISORS LLC, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, Almitas Capital LLC, GOLDMAN SACHS GROUP INC, and VANGUARD GROUP INC. This page lists 87 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
84
Q4 2023 holders
87
Holder diff
3
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .